Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Pharmaceutical Business Review
Return to: PBR Home
Search Refinements

News

View news from other Pharmaceutical sectors:
136-150 of 48521 results
Samsung Bioepis' Enbrel biosimilar secures European Commission approval
By PBR Staff Writer
Samsung Bioepis, a joint venture between Samsung BioLogics and Biogen, has secured approval from the European Commission for Benepali, a biosimilar of Amgen's Enbrel rheumatoid arthritis drug.
Regulatory Affairs > News
FDA approves two new indications for Novartis' Cosentyx psoriasis drug
By PBR Staff Writer
Novartis has secured approval from the US Food and Drug Administration (FDA) for two new indications of Cosentyx psoriasis drug.
Regulatory Affairs > News
AMRI signs collaboration deal with New York Center for Nanomedicine Research
Albany Molecular Research (AMRI) has signed a collaboration agreement with the New York Center for Nanomedicine Research (NYCNMR) to co-market their nanotechnology services to global pharmaceutical and biotechnology clients.
Contract Research & Services > Contract Services > News
Boehringer Ingelheim, Arena Pharmaceuticals partner to advance research in schizophrenia
Boehringer Ingelheim and Arena Pharmaceuticals have signed an exclusive agreement to conduct joint research to identify drug candidates targeting an undisclosed G protein-coupled receptor (GPCR), which belongs to the group of orphan CNS receptors.
Contract Research & Services > Contract Research > News
Janssen starts phase 2/3 trial of imetelstat in myelodysplastic syndromes
By PBR Staff Writer
Janssen Research & Development has started the phase 2/3 clinical trial to evaluate imetelstat in patients with myelodysplastic syndromes (MDS).
Contract Research & Services > Clinical Trials > News
Karyopharm starts clinical trial of oral selinexor in advanced liposarcoma
By PBR Staff Writer
Clinical-stage pharmaceutical firm Karyopharm Therapeutics has started a new phase 2/3 clinical trial oral selinexor in advanced liposarcoma.
Contract Research & Services > Clinical Trials > News
NeuroVive Pharmaceutical acquires minority stake in Isomerase Therapeutics
By PBR Staff Writer
NeuroVive Pharmaceutical has acquired a 5% stake in the UK-based drug discovery and development firm Isomerase Therapeutics.
Drug Research > Drug Discovery & Development > News
TheraKine, Cell Care Therapeutics sign license and development deal
TheraKine and Cell Care Therapeutics have entered into a licensing agreement to use TheraKine's injectable sustained release technology to enable Cell Care's stem cell therapies for diseases of the eye that commonly cause blindness.
Contract Research & Services > Contract Services > News
Turing receives no objection letter from Health Canada to start TUR-002 program clinical study
Turing Pharmaceuticals has received a No Objection Letter from Health Canada to initiate the first clinical study for its TUR-002 program.
Contract Research & Services > Clinical Trials > News
Syros Pharmaceuticals closes $40m financing of preferred stock
Syros Pharmaceuticals has closed a $40m financing of preferred stock.
Drug Research > Drug Delivery > News
Cepheid forms diagnostic collaboration with MedImmune and COMBACTE
Cepheid has formed a collaboration with MedImmune, the global biologics research and development arm of AstraZeneca, and COMBACTE, a European public/private partnership set up to promote the development of new drugs in the anti-infectives field, to develop a series of rapid diagnostic tests to identify Staphylococcus aureus (S. aureus) and Pseudomonas aeruginosa (P. aeruginosa) in respiratory secretions of mechanically ventilated patients.
Contract Research & Services > Contract Services > News
ThromboGenics enrolls first patient in phase II CIRCLE study
ThromboGenics has been enrolled first patient in its Phase II CIRCLE study evaluating the efficacy and safety of multiple doses of ocriplasmin in inducing total posterior vitreous detachment (PVD) in patients with non-proliferative diabetic retinopathy (NPDR).
Contract Research & Services > Clinical Trials > News
Debiopharm, EORTC partner to investigate Triptorelin for treatment of salivary gland cancers
Debiopharm International has announced a collaboration in order to supply triptorelin pamoate 3.75 mg 1-month formulation for patients suffering from salivary cancer participating in a clinical study sponsored by the European Organisation for Research and Treatment of Cancer (EORTC).
Contract Research & Services > Contract Services > News
Oxford BioMedica wins UK MHRA approval to manufacture bulk drug material at Yarnton plant
Oxford BioMedica has received approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to manufacture bulk drug material for Investigational Medicinal Products (IMPs) at the Group’s recently established and commissioned specialist biomanufacturing facility in Yarnton, Oxford, UK.
Production & Manufacturing > Manufacturing > News
US FTC clears Galapagos and Gilead's global partnership on filgotinib
By PBR Staff Writer
Galapagos and Gilead Sciences have secured approval from the US Federal Trade Commission (FTC) for their global partnership agreement on filgotinib.
Regulatory Affairs > News
136-150 of 48521 results